Cardiopulmonary exercise factors predict survival in patients with advanced interstitial lung disease referred for lung transplantation

Respiratory Medicine

Volumn 126, Issue , 2017, Pages 59-67

  Layton, Aimee M ^a   Armstrong, Hilary F ^a,b   Kim, Hanyoung P ^c   Meza, Kimbery S ^e   D'Ovidio, Frank ^d   Arcasoy, Selim M ^a,d  

^a Department of Medicine   (United States)

^b Department of Medicine   (United States)

^c NEW YORK PRESBYTERIAN HOSPITAL   (United States)

^d NONE   (United States)

^e Program on US Russia Relations at Columbia s Harriman Institute   (United States)

Author keywords

Cardiopulmonary exercise; Lung transplant; Prognosis; Pulmonary fibrosis; Survival

Indexed keywords

ADULT; ARTICLE; CARDIOPULMONARY EXERCISE TEST; FEMALE; HUMAN; INTERSTITIAL LUNG DISEASE; LUNG HEMODYNAMICS; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT REFERRAL; PREDICTIVE VALUE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SIX MINUTE WALK TEST; SPIROMETRY; SURVIVAL; AGED; CROSS-SECTIONAL STUDY; EXERCISE TEST; EXERCISE TOLERANCE; LUNG FUNCTION TEST; METABOLISM; MIDDLE AGED; MORTALITY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; STATISTICS AND NUMERICAL DATA; SUPPLY AND DISTRIBUTION; VITAL CAPACITY;

CARBON MONOXIDE; OXYGEN;

AGED; CARBON MONOXIDE; CROSS-SECTIONAL STUDIES; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HUMANS; LUNG DISEASES, INTERSTITIAL; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; OXYGEN; PREDICTIVE VALUE OF TESTS; RESPIRATORY FUNCTION TESTS; SURVIVAL; VITAL CAPACITY;

EID: 85016445805     PISSN: 09546111     EISSN: 15323064     Source Type: Journal    
DOI: 10.1016/j.rmed.2017.03.022     Document Type: Article

References (29)

1. [1] Valapour, M., Skeans, M.A., Smith, J.M., et al. OPTN/SRTR 2015 annual data report: lung. Am. J. Transpl. 17:Suppl 1 (2017), 357–424.
2. [2] McCurry, K.R., Shearon, T.H., Edwards, L.B., et al. Lung transplantation in the United States. 1998-2007 Am. J. Transpl. 9:4 Pt 2 (2009), 942–958.
3. [3] Raghu, G., Collard, H.R., Egan, J.J., et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am. J. Respir. Crit. Care Med. 183:6 (2011), 788–824.
4. [4] van der Plas, M.N., van Kan, C., Blumenthal, J., Jansen, H.M., Wells, A.U., Bresser, P., Pulmonary vascular limitation to exercise and survival in idiopathic pulmonary fibrosis. Respirology 19:2 (2013), 269–275.
5. [5] King, T.E. Jr., Tooze, J.A., Schwarz, M.I., Brown, K.R., Cherniack, R.M., Predicting survival in idiopathic pulmonary fibrosis: scoring system and survival model. Am. J. Respir. Crit. Care Med. 164:7 (2001), 1171–1181.
6. [6] Fell, C.D., Liu, L.X., Motika, C., et al. The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 179:5 (2009), 402–407.
7. [7] Gay, S.E., Kazerooni, E.A., Toews, G.B., et al. Idiopathic pulmonary fibrosis: predicting response to therapy and survival. Am. J. Respir. Crit. Care Med. 157:4 Pt 1 (1998), 1063–1072.
8. [8] Triantafillidou, C., Manali, E., Lyberopoulos, P., et al. The role of cardiopulmonary exercise test in IPF prognosis. Pulm. Med., 2013, 2013, 514817.
9. [9] Lederer, D.J., Arcasoy, S.M., Wilt, J.S., D'Ovidio, F., Sonett, J.R., Kawut, S.M., Six-minute-walk distance predicts waiting list survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 174:6 (2006), 659–664.
10. [10] Lama, V.N., Flaherty, K.R., Toews, G.B., et al. Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am. J. Respir. Crit. Care Med. 168:9 (2003), 1084–1090.
11. [11] Ley, B., Collard, H.R., King, T.E. Jr., Clinical course and prediction of survival in idiopathic pulmonary fibrosis. Am. J. Respir. Crit. Care Med. 183:4 (2011), 431–440.
12. [12] Jones, N.L.C.E., Clinical Exercise Testing. 1982, W.B. Saunders Co., Philadelphia.
13. [13] Miller, M.R., Crapo, R., Hankinson, J., et al. General considerations for lung function testing. Eur. Respir. J. 26:1 (2005), 153–161.
14. [14] Galie, N., Hoeper, M.M., Humbert, M., et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur. Respir. J. 34:6 (2009), 1219–1263.
15. [15] ATS/ACCP, ATS/ACCP Statement on cardiopulmonary exercise testing. Am. J. Respir. Crit. Care Med. 167:2 (2003), 211–277.
16. [16] Kreider, M., Kotloff, R.M., Selection of candidates for lung transplantation. Proc. Am. Thorac. Soc. 6:1 (2009), 20–27.
17. [17] Egan, T.M., Murray, S., Bustami, R.T., et al. Development of the new lung allocation system in the United States. Am. J. Transpl. 6:5 Pt 2 (2006), 1212–1227.
18. [18] Weill, D., Benden, C., Corris, P.A., et al. A consensus document for the selection of lung transplant candidates: 2014–an update from the pulmonary transplantation council of the international society for heart and lung transplantation. J. Heart Lung Transpl. 34:1 (2015), 1–15.
19. [19] Panagiotou, M., Polychronopoulos, V., Strange, C., Respiratory and lower limb muscle function in interstitial lung disease. Chron. Respir. Dis. 2:13 (2016), 162–172.
20. [20] Meyer, K.C., Danoff, S.K., Lancaster, L.H., Nathan, S.D., Management of idiopathic pulmonary fibrosis in the elderly patient: addressing key questions. Chest 148:1 (2015), 242–252.
21. [21] Mendes, P., Wickerson, L., Helm, D., et al. Skeletal muscle atrophy in advanced interstitial lung disease. Respirology 20:6 (2015), 953–959.
22. [22] Kozu, R., Senjyu, H., Jenkins, S.C., Mukae, H., Sakamoto, N., Kohno, S., Differences in response to pulmonary rehabilitation in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Respiration 81:3 (2011), 196–205.
23. [23] Wickerson, L., Mathur, S., Helm, D., Singer, L., Brooks, D., Physical activity profile of lung transplant candidates with interstitial lung disease. J. Cardiopulm. Rehabil. Prev. 33:2 (2013), 106–112.
24. [24] Rahman, I., Skwarska, E., Henry, M., et al. Systemic and pulmonary oxidative stress in idiopathic pulmonary fibrosis. Free Radic. Biol. Med. 27:1–2 (1999), 60–68.
25. [25] O'Donnell, D.E., Chau, L.K., Webb, K.A., Qualitative aspects of exertional dyspnea in patients with interstitial lung disease. (1985) J. Appl. Physiol. 84:6 (1998), 2000–2009.
26. [26] Flaherty, K.R., Andrei, A.C., Murray, S., et al. Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am. J. Respir. Crit. Care Med. 174:7 (2006), 803–809.
27. [27] Hallstrand, T.S., Boitano, L.J., Johnson, W.C., Spada, C.A., Hayes, J.G., Raghu, G., The timed walk test as a measure of severity and survival in idiopathic pulmonary fibrosis. Eur. Respir. J. 25:1 (2005), 96–103.
28. [28] du Bois, R.M., Weycker, D., Albera, C., et al. Six-minute-walk test in idiopathic pulmonary fibrosis: test validation and minimal clinically important difference. Am. J. Respir. Crit. Care Med. 183:9 (2011), 1231–1237.
29. [29] Lettieri, C.J., Nathan, S.D., Barnett, S.D., Ahmad, S., Shorr, A.F., Prevalence and outcomes of pulmonary arterial hypertension in advanced idiopathic pulmonary fibrosis. Chest 129:3 (2006), 746–752.